申请人:Daiichi Sankyo Company, Limited
公开号:EP3168219A1
公开(公告)日:2017-05-17
It is intended to provide a novel compound or a salt thereof, or crystals of the compound or the salt, which inhibit Axl and are useful in the treatment of a disease caused by hyperfunction of Axl, the treatment of a disease associated with hyperfunction of Axl, and/or the treatment of a disease involving hyperfunction of Axl.
[Solution]
The present invention provides a pyridone derivative having a tetrahydropyranylmethyl group represented by the following formula (I) having various substituents, or a salt thereof, or crystals of the compound or the salt (wherein R1, R2, R3, R4, R5, W, X, Y, and Z are each as defined in the specification).
本发明旨在提供一种新型化合物或其盐,或该化合物或其盐的结晶,该化合物或其盐可抑制 Axl,并可用于治疗由 Axl 功能亢进引起的疾病、治疗与 Axl 功能亢进相关的疾病和/或治疗涉及 Axl 功能亢进的疾病。
[解决方案]
本发明提供一种吡啶酮衍生物,该衍生物具有下式(I)所代表的具有各种取代基的四氢吡喃甲基,或其盐,或该化合物或该盐的结晶(其中R1、R2、R3、R4、R5、W、X、Y和Z各自如说明书中所定义)。